Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Netherlands

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 15, Issue 11, 1996, Pages 861-864

  Van Zwet, A A ^a   De Boer, W A ^b   Schneeberger, P M ^c   Weel, J ^d   Jansz, A R ^e   Thijs, J C ^a  

^a Bethesda Hospital   (Netherlands)

^b ST ANNA HOSPITAL   (Netherlands)

^c JEROEN BOSCH HOSPITAL   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e Stichting Laboratoria voor Pathologie en Medische Microbiologie   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CLARITHROMYCIN; MACROLIDE; METRONIDAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NETHERLANDS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL;

EID: 0029750265     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf01691216     Document Type: Article

References (29)

1. Thijs JC, Kuipers EJ, van Zwet AA, Peña AS, de Graaff J: Treatment of Helicobacter pylori infections. A review of the current indications. Quarterly Journal of Medicine 1995, 88: 369-389.
2. Bazzoli F, Zagari RM, Fossi S, Pozzato P, Alampi G, Simoni P: Short-term low-dose triple therapy for the eradication of Helicobacter pylori. European Journal of Gastroenterology and Hepatology 1994, 6: 773-777.
3. de Boer WA, Driessen WMM, Potters VPJ, Tytgat GNJ: Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. American Journal of Gastroenterology 1994, 89: 1993-1997.
4. de Boer WA, Tytgat GNJ: The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice? Scandinavian Journal of Gastroenterology 1995, 30: 401-407.
5. Burette A, Glupczynski Y, De Prez C: Evaluation of various multidrug eradication regimens for Helicobacter pylori. European Journal of Gastroenterology and Hepatology 1992, 4: 817-823.
6. Burette A, Glupczynski Y: Helicobacter pylori: the place of the new macrolides in the eradication of bacteria in peptic ulcer disease. Infection 1995, 23, Supplement 1: 44-52.
7. Cayla R, Zerbib F, Talbi P, Megraud F, Lamouliatte H: Pre-and post-treatment clarithromycin resistance of Helicobacter pylori strains: a key factor of treatment failure. Gut 1995, 37, Supplement 1: A55, abstract 217.
8. European Study Group on Antibiotic Susceptibility of H. pylori. Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases 1992, 11: 777-781.
9. Goodwin CS, Marshall BJ, Blincow ED, Wison DH, Blackbourn S, Phillips M: Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. Journal of Clinical Pathology 1988, 41: 207-210.
10. Parasakthi N, Goh KL: Primary and acquired resistance to clarithromycin among Helicobacter pylori strains in Malaysia. American Journal of Gastroenterology 1995, 90: 519.
11. van Zwet AA, Thijs JC, Oom JAJ, Hoogeveen J, Düringshoff BL: Failure to eradicate Helicobacter pylori in patients with metronidazole resistant strains. European Journal of Gastroenterology and Hepatology 1993, 5: 185-186.
12. Xia HX, Buckley M, Hyde D, Keane CT, O'Morain CA: Effects of antibiotic resistance on clarithromycin-combined triple therapy for Helicobacter pylori. Gut 1995, 37, Supplement 1: A55, abstract 218.
13. Glupczynski Y: In vitro susceptibility testing of Helicobacter pylori to antimicrobial agents: basis for treatment or microbiologists' obsession? Zeitblatt für Bakteriologie 1993, 280: 227-238.
14. Malanoski GJ, Eliopoulos GM, Ferraro MJ, Moellering JR: Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin. European Journal of Clinical Microbiology & Infectious Diseases 1993, 12: 131-133.
15. Peterson W: Clarithromycin as monotherapy for eradication of Helicobacter pylori. American Journal of Gastroenterology 1992, 87: 1274.
16. Logan RP, Gummett PA, Schaufelberger HD, Greaves RR, Mendelson GM, Thomas PH, Baron JH, Misiewicz JJ: Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 1994, 35: 323-326.
17. al-Assi MT, Ramirez FC, Lew GM, Genta RM, Graham DY: Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection. American Journal of Gastroenterology 1994, 89: 1203-1205.
18. Thijs JC, van Zwet AA, Moolenaar W, Oom JAJ, de Korte H, Runhaar EA: Clarithromycin, an alternative to metronidazole in the triple therapy of Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics 1994, 8: 131-134.
19. Rautelin H, Seppälla K, Renkonen OV, Vaino U, Kosunen TU: Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrobial Agents and Chemotherapy 1992, 36: 163-166.
20. Cederbrant G, Kahlmeter G, Ljungh A: The E-test for antimicrobial susceptibility testing of Helicobacter pylori. Journal of Antimicrobial Chemotherapy 1993, 31: 65-71.
21. Glupczynski Y, Labbé M, Hansen W, Crokaert F, Yourassowsky E: Evaluation of the E-test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. Journal of Clinical Microbiology 1991, 29: 2072-2075.
22. Cayla R, Lamouiliatte H, Megraud F, Quinton A: Primary resistance of Helicobacter pylori strains to metronidazole and to Clarithromycin in France in 1993. Gastroenterology 1994, 106: A61.
23. Xia HX, Keane CT, O'Morain CA: Prevalence and stability of Clarithromycin resistance in Helicobacter pylori: clinical implications. American Journal of Gastroenterology 1994, 89: 1391.
24. Hachem CY, Clarridge JE, Evans DG, Cox S, Flamm R, Graham DY: Analysis of pretreatment in vitro microbiology to evaluate eradication of H. pylori in patients with duodenal ulcers. American Journal of Gastroenterology 1994, 89: 1373.
25. Becx MCJM, Janssen AJHM, Clasener HAL, de Koning RW: Metronidazole-resistant Helicobacter pylori. Lancet 1990, i: 976-977.
26. van Zwet AA, Thijs JC, Schievink-de Vries W, Schiphuis J, Snijder JAM: In vitro studies on the stability and development of metronidazole resistance in Helicobacter pylori. Antimicrobial Agents and Chemotherapy 1994, 38: 360-362.
27. Versalovic J, Shortridge D, Kibler K, Griffy MV, Beyer J, Flamm RK, Tanaka SK, Graham DY, Go MF: Mutations in 23S rRNA are associated with Clarithromycin resistance in Helicobacter pylori. Antimicrobial Agents and Chemotherapy 1996, 40: 477-480.
28. Graham DY: A reliable cure of Helicobacter pylori infection? Gut 1995, 37: 154-156.
29. van Zwet AA, Thijs JC, Roosendaal R, Kuipers EJ, Peña S, de Graaff J: Practical diagnosis of Helicobacter pylori infection. European Journal of Gastroenterology and Hepatology 1996, 8: 501-506.